GKNM Hospital > Oncology > Dr.A. Raj Kumar
Consultant Medical Oncologist

Dr.A. Raj Kumar

MBBS , MD-(RT, DM – Oncology)

Doctor Schedule
Mon - Fri10am - 4pm
Languages
  • English, Tamil
Specialty
Medical Oncology

Research Experience

  • Concurrent chemoradiation in head and neck cancers (2000). This is a prospective study spanning two years. This study was submitted as a dissertation to the TN Dr. MGR Medical University as a mandatory requirement of my residency training in Radiation Oncology.
  • Utility and feasibility of anato-metabolic imaging in brain tumors. This was a prospective study done during my senior residency under the guidance of Dr.N.R. Datta, Professor of Radiation Oncology, SGPGIMS, Lucknow. This paper was presented at the Annual conference of UP Chapter of Association of Radiation Oncologists of India (AROI), Lucknow,2001.
  • Prevalence of Helicobacter pylori in patients with carcinoma stomach- Our Experience. This was a prospective study done during my senior residency in Medical Oncology that analysed the prevalence of H.pylori among patients with carcinoma stomach at Madras Medical College. This paper was presented at the XI Biennial Conference of Indian Society of Oncology and XIII Biennial Conference of Indian Society of Medical & Pediatric Oncology at Bangalore 2004.

Clinical Trials

  • A mutinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Drug X in the prevention of venous thromboembolism in cancer patients at high risk for VTE and who are undergoing chemotherapy.
  • A study of Drug X in Combination with Paclitaxel plus Cisplatin in Advanced NSCLC
  • Phase II single-arm study of Drug X by 4-hr infusion in patients with recurring platinum-resistant ovarian cancer
  • A randomised phase II study comparing Drug X-pemetrexed, pemetrexed alone and Drug X alone as second line treatment for non-smoker patients with locally advanced or metastatic NSCLC
  • A Multinational,Randomized,double- blind,placebo controlled study to evaluate the efficacy and safety of xxxxxx in the prevention of Venous Thromboembolism(VTE) in cancer patients at high risk for VTE and who are undergoing chemotherapy(protocol EFC6521)
  • A Phase II Study to Determine the Safety, Efficacy, and Pharmacokinetics of Multiple Intravenous Doses of Drug X 80 mg, 160 mg, and 320 mg Versus Placebo Administered to Patients with Non-Small Cell Lung Cancer-Related Fatigue and Cachexia
  • Phase II study to evaluate the safety, tolerability and efficacy of FOLFOX + Drug X versus FOLFOX alone administered intravenously to patients with colorectal adenocarcinoma previously untreated for metastatic disease
  • A phase III study of Erbb2 Positive Advanced or Metastatic Gastric or Esophageal or Gastroesophageal junction adenocarcinoma treated with capecitabine plus Oxaliplatin with or without Drug X
  • Prospective, multi-centric, randomized open-label, two-arm, parallel group, active-control, comparative  clinical study to evaluate efficacy, safety and pharmacokinetics of R-TPR-033 / ERBITUX® in patients with recurrent locoregional or metastatic squamous cell carcinoma of the head and neck.
  • MYL-Her3001-A multicenter, double-blind, randomized, parallel-group, phase III study of the efficacy and safety of Hercules plus taxane versus Herceptin® plus taxane as first line therapy in patients with HER2-positive metastatic breast cancer
  • A Prospective, Multicenter, Observational Study Examining The clinical Utility Of Canscript In Routine Clinical Practice”.

Honors and Awards

  • Best Scientific Paper award at the XIV Annual conference of UP Chapter of Association of Radiation Oncologists of India (AROI), Lucknow,2001.
  • J.M. Pinto Memorial Award for the Best Paper, 23rd Annual National Conference of Association of Radiation Oncologists of India (AROI), Chandigarh, 2001.

Clinical Research and Academic

  • Best Scientific Paper award at the XIV Annual conference of UP Chapter of Association of Radiation Oncologists of India (AROI), Lucknow,2001.
  • J.M. Pinto Memorial Award for the Best Paper, 23rd Annual National Conference of Association of Radiation Oncologists of India (AROI), Chandigarh, 2001.

Publications

  • Giant cell tumour of the occipital bone-A case report with review of literature. Journal of Clinical Radiotherapy and Oncology 2001; (3): 41-44. A.Rajkumar, V.Elhence, N.R.Datta et al.
  • Radiation therapy for sacral osteoblastoma. Clinical Oncology 2003; 15(2): 85-86. A.Rajkumar, R.Basu, N.R.Datta et al.
  • Tumour regression dynamics with external radiotherapy in cancer cervix and it’s implications.  Indian Journal of Cancer 2004;Vol 41(1): 18-24. N.R.Datta, A.Rajkumar, R.Basu, et al.
  • Summated chemotherapy dose intensity versus loco- regional response in locally advanced breast cancer :It’s possible implications. Indian Journal of Cancer 2003; 40(4):127-134. N.R.Datta, A.Rajkumar, R.Basu et al.
  • Anaphylaxis to cisplatin following nine previously uncomplicated cycles.International Journal of Clinical Oncology;Vol 7(6): 365-367.R. Basu, A.Rajkumar, N.R.Datta.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
dots